Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01355419
Other study ID # AK/10-07-45/3912
Secondary ID
Status Completed
Phase N/A
First received May 6, 2011
Last updated April 27, 2015
Start date August 2010
Est. completion date August 2014

Study information

Verified date April 2015
Source Centre Hospitalier Universitaire Saint Pierre
Contact n/a
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Observational

Clinical Trial Summary

In Obstructive sleep apnea (OSA) patients, sleep is disrupted and sleep quality is very poor. The investigators can suppose that with continuous positive airway pressure (CPAP) therapy, there is an improvement in sleep quality, such that patients need less sleep to be fit. Sleep schedules on mid term periods in OSA patients under CPAP therapy has not been studied. The investigators have planned to study sleep schemes before and after CPAP therapy in moderate to severe sleepy OSA patients.


Description:

In Obstructive sleep apnea (OSA) patients, sleep is disrupted and sleep quality is very poor. The investigators can suppose that with CPAP therapy, there is an improvement in sleep quality, such that patients need less sleep to be fit. Patients often report this fact, but it has not been objectivated.

Sleep schedules on mid term periods in OSA patients under CPAP therapy has not been studied. The investigators have planned to study sleep schemes before and after CPAP therapy in moderate to severe sleepy OSA patients. Sleep schemes and physical activity will be studied with actigraphy.

Study Design : prospective study. Number of patients supposed to be studied: 190

Methods:

Patients Ø OSA patients assessed by polysomnography, showing apnea-hypopnea index > 20, and Epworth Sleepiness Scale Score(ESS) >10 Ø Indication of CPAP therapy

Initial Evaluation :

- Phase 1

- ESS

- BMI

- Questionnaire : Nottingham health profile

- Comorbidities -medical therapy

- Smoking/alcohol Consumption

- Then, we give an Actigraph (Body Media Sense WearÒ) to the patients, that he has to wear during 7 complete days

- Phase 2

- Actigraphy report

- Start of CPAP therapy(pressure adjusted according to autoCPAP device report after minimum one night)

Second Evaluation, after 3 months under CPAP:

- Phase 1

§ ESS

- BMI

- CPAP observance report to calculate mean use/day

- Questionnaire : Nottingham health profile

- Actigraph (Body Media Sense WearÒ) to the patients, that he has to wear during 7 complete days

- Phase 2: after 1 week under CPAP and actigraphy

- Actigraphy report

- CPAP observance report

- CPAP Tolerance Questionnaire Ø


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date August 2014
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Moderate to severe OSA

- sleepy (sleepiness assessed by Epworth Sleepiness Scale)

- indication for CPAP therapy

Exclusion Criteria:

- narcolepsy

- age < 18

- non sleepy Moderate to severe OSA

- no CPAP treatment required

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
Belgium CHU St Pierre Brussels

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Saint Pierre

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Total Sleep Time Before and After CPAP Therapy in Obstructive Sleep Apnea Patients change in Total sleep time before and after CPAP therapy in obstructive sleep apnea patients, assessed by actigraphy baseline and at 3 months No
Secondary Change in Physical Activity (Number of Steps/Day)Before and After CPAP Therapy in OSA Patients Change in Physical activity (number of steps/day)before and after CPAP therapy in OSA patientsevaluated by actigraphy baseline and at 3 months No
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Completed NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Not yet recruiting NCT06467682 - 12-week Tele-exercise Program in Patients With OSA N/A
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A